| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Articles: Hormones and Reproductive Health |
Population Council and The Rockefeller University (Q.L., M.K.B., I.C.B.), New York, New York 10021; and Department of Obstetrics/Gynecology (S.K., A.D., Y.-K.Y.), Nassau University, East Meadow, New York 11554
Address all correspondence and requests for reprints to: Indrani C. Bagchi, Ph.D., Department of Veterinary Biosciences, University of Illinois at UrbanaChampaign, 2001 South Lincoln, Urbana, Illinois 61802. E-mail: ibagchi{at}uiuc.edu
Abstract
The putative window of embryo implantation in the human opens between
days 1924 of the menstrual cycle. During this period, the endometrium
undergoes distinctive structural and functional changes orchestrated by
steroid hormones, growth factors, and cytokines to attain a receptive
phase in which it acquires the ability to implant the developing
embryo. A major challenge in the study of human reproduction is to
identify the molecular signals that participate in the establishment of
this critical receptive phase in the context of the natural cycle.
Toward this goal, we analyzed human endometrial biopsies at various
days of the menstrual cycle by employing messenger RNA (mRNA)
differential display technique. We isolated several complementary DNAs
representing genes that are either up- or down-regulated within the
putative window of implantation. We identified one of these genes as
that encoding interferon (IFN)-inducible guanylate-binding protein 1
(or GBP1), which possesses GTPase activity. Analysis of
endometrial biopsies by Northern blotting and RT-PCR demonstrated that
GBP1 mRNA is specifically induced at the midsecretory phase of the
menstrual cycle. In situ hybridization analysis revealed
that GBP1 mRNA expression is localized in the glandular epithelial
cells as well as in the stroma in the immediate vicinity of the glands.
We observed that treatment of human endometrial adenocarcinoma cell,
Ishikawa, with IFN-
or IFN-
markedly induced the expression of
GBP1 mRNA. IFN-
was, however, a more potent inducer of GBP1 than
IFN-
. Consistent with this finding, the temporal profile of GBP1
expression during the menstrual cycle resembled that of IFN-
mRNA
more closely than that of IFN-
, predicting a regulatory role of
IFN-
in GBP1 expression in midsecretory human endometrium. Although
the precise function of GBP1 in the receptive human uterus remains
unclear, its unique expression overlapping the putative window of
implantation suggests that it might serve as a useful marker of uterine
receptivity in the human.
This article has been cited by other articles:
![]() |
C. Klein, S. Bauersachs, S. E. Ulbrich, R. Einspanier, H. H.D. Meyer, S. E.M. Schmidt, H.-D. Reichenbach, M. Vermehren, F. Sinowatz, H. Blum, et al. Monozygotic Twin Model Reveals Novel Embryo-Induced Transcriptome Changes of Bovine Endometrium in the Preattachment Period Biol Reprod, February 1, 2006; 74(2): 253 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zoumpoulidou, M. C. Jones, S. F. de Mattos, J. M. Francis, L. Fusi, Y. S. Lee, M. Christian, R. Varshochi, E. W.-F. Lam, and J. J. Brosens Convergence of Interferon-{gamma} and Progesterone Signaling Pathways in Human Endometrium: Role of PIASy (Protein Inhibitor of Activated Signal Transducer and Activator of Transcription-y) Mol. Endocrinol., August 1, 2004; 18(8): 1988 - 1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, Y. Choi, F. W. Bazer, and T. E. Spencer Identification of Genes in the Ovine Endometrium Regulated by Interferon {tau} Independent of Signal Transducer and Activator of Transcription 1 Endocrinology, December 1, 2003; 144(12): 5203 - 5214. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lubeseder-Martellato, E. Guenzi, A. Jorg, K. Topolt, E. Naschberger, E. Kremmer, C. Zietz, E. Tschachler, P. Hutzler, M. Schwemmle, et al. Guanylate-Binding Protein-1 Expression Is Selectively Induced by Inflammatory Cytokines and Is an Activation Marker of Endothelial Cells during Inflammatory Diseases Am. J. Pathol., November 1, 2002; 161(5): 1749 - 1759. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |